Arix Bioscience PLC | Finanzwire

PRESS RELEASE

published on 11/03/2023 at 17:30, 3 years ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/02/2023 at 19:20, 3 years ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/01/2023 at 17:30, 3 years ago

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
PRESS RELEASE

published on 10/24/2023 at 08:00, 3 years ago

Portfolio company Harpoon Therapeutics announces up to $150 million private placement
PRESS RELEASE

published on 10/06/2023 at 08:00, 3 years 1 month ago

Unaudited NAV for September 2023
PRESS RELEASE

published on 09/27/2023 at 08:01, 3 years 1 month ago

Interim Results for the Six Months Ended 30 June 2023
PRESS RELEASE

published on 09/27/2023 at 08:00, 3 years 1 month ago

Board Change
PRESS RELEASE

published on 09/14/2023 at 08:01, 3 years 1 month ago

Notice of Results and Investor Presentation
PRESS RELEASE

published on 09/14/2023 at 08:00, 3 years 1 month ago

Unaudited NAV for August 2023
PRESS RELEASE

published on 08/07/2023 at 08:00, 3 years 3 months ago

Unaudited NAV for July 2023

Published on 11/06/2026 at 18:00, 23 hours 11 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 23 hours 11 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 23 hours 16 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 23 hours 36 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 1 day 6 hours ago

voting rights

News